Background illustration for clinical trials search

Paid Clinical Trials Bellevue

Discover 611 paid clinical trials in Bellevue, Nebraska. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

for
B Acute Lymphoblastic Leukemia
Location: Omaha NE, Des Moines IA, Kansas City MO, Sioux Falls SD,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 46

Code: NCT06124157

Phase 2, Recruiting

Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs

for
Failed or Difficult Intubation, Sequela, Intubation; Difficult,
Location: Omaha NE, Madison WI, Shorewood Hills WI, Milwaukee WI,
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0+

Code: NCT02493478

Recruiting

The Pediatric Anesthesia Quality Improvement Project

for
Surgery, Anesthesia, Children
Location: Omaha NE, Iowa City IA, ST Louis MO, Chicago IL,
Sponsor: The Society for Pediatric Anesthesia

Sex: All

Age: 0 - 21

Code: NCT00674388

Recruiting

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

for
Dravet Syndrome
Location: Omaha NE, Little Rock AR, Louisville KY, Cincinnati OH,
Sponsor: Epygenix

Sex: All

Age: 2+

Code: NCT04462770

Phase 3, Recruiting

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

for
Pediatric Migraine
Location: Omaha NE, Sioux City IA, West Des Moines IA,
Sponsor: Pfizer

Sex: All

Age: 6 - 17

Code: NCT04649242

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

for
Acute Treatment of Migraine
Location: Omaha NE, West Des Moines IA, Kansas City KS,
Sponsor: Pfizer

Sex: All

Age: 6 - 17

Code: NCT04743141

Phase 3, Recruiting

Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections

for
Pulmonary Invasive Fungal Infections,
Location: Omaha NE, Kansas City MO, Saint Paul MN, Saint Louis MO,
Sponsor: Arkansas Children's Hospital Research Institute

Sex: All

Age: 0 - 21

Code: NCT03827694

Recruiting

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

for
Acute Leukemia of Ambiguous Lineage,
Location: Omaha NE, Des Moines IA, Kansas City MO, Sioux Falls SD,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 1

Code: NCT06317662

Phase 2, Recruiting

A Clinical Trial Comparing 2x/Day for 30-minutes Use of the Emanate Perio PODS Post-SRP to a Control Group Post-SRP.

for
Periodontitis (Stage 3)
Location: La Vista NE, Spring TX, Houston TX, Victoria TX,
Sponsor: McGuire Institute

Sex: All

Age: 30 - 70+

Code: NCT06914596

Recruiting

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

for
Oligometastatic Prostate Cancer (OMPC)
Location: Omaha NE, Des Moines IA, Kansas City KS, Rochester MN,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT05939414

Phase 3, Recruiting

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

for
Non-Muscle Invasive Bladder Cancer
Location: Omaha NE, Wichita KS, St Louis MO, Chicago IL,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06319820

Phase 3, Recruiting

Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women

for
Overactive Bladder, Overactive Bladder (OAB),
Location: Omaha NE, Wichita KS, Winston-Salem NC, Boise ID,
Sponsor: InMode MD Ltd.

Sex: Female

Age: 22 - 70+

Code: NCT07209397

Recruiting

IC-8 Apthera IOL New Enrollment Post Approval Study

for
Cataract, Presbyopia, Posterior Capsule Opacification
Location: Omaha NE, Wichita KS, Rock Island IL, Indianapolis IN,
Sponsor: Bausch & Lomb Incorporated

Sex: All

Age: 22+

Code: NCT06060041

Recruiting

Investigator Initiated Study to Assess the Efficacy of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease Following Photorefractive Keratectomy (PRK)

for
Dry Eye
Location: Omaha NE
Sponsor: Brandon Baartman

Sex: All

Age: 18+

Code: NCT05045508

Phase 3, Recruiting

Contoura With Phorcides Compared to Wavefront Optimized LASIK

for
Myopia, Astigmatism
Location: Omaha NE, Sioux Falls SD, Fargo ND, Bozeman MT
Sponsor: Daniel Terveen

Sex: All

Age: 21 - 38

Code: NCT05486546

Recruiting

CAN-Stim Compared to SNS in Treatment of Urinary Urgency Incontinence With Wireless Neuromodulation Technology

for
Urinary Incontinence, Urge
Location: Omaha NE, Saint Louis MO, Dallas TX, Royal Oak MI,
Sponsor: Uro Medical Corporation

Sex: All

Age: 18+

Code: NCT02577302

Recruiting

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

for
High-Risk Non-Muscle-Invasive Bladder Cancer
Location: Omaha NE, Clive IA, Wichita KS, Rochester MN,
Sponsor: CG Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06567743

Phase 2, Recruiting

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

for
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Location: Omaha NE, Clive IA, Wichita KS, Quincy IL, Rochester MN,
Sponsor: Ferring Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06510374

Phase 3, Recruiting

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Omaha NE, Kansas City KS, Edwardsville IL, Chicago IL,
Sponsor: Dianthus Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06858579

Phase 3, Recruiting

A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer

for
Metastatic Castration-Resistant Prostate Cancer
Location: Omaha NE, Chicago IL, Tampa FL, Boston MA, Miami FL
Sponsor: AstraZeneca

Sex: Male

Age: 18+

Code: NCT06879041

Phase 1, Recruiting